Latest Hemispherx Biopharma Inc. Stories
TSX Venture: QPT EDMONTON, April 14 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. (TSX-V: QPT) ("Quest" or the "Company"), a pharmaceutical company developing and commercializing products for the treatment of cancer, today announced a clinical development arrangement with U.S.
PHILADELPHIA, Nov. 16, 2010 /PRNewswire/ -- Berger & Montague, P.C. and Brower Piven, A Professional Corporation, Co-Lead Counsel for Lead Plaintiff and the Class in the Hemispherx Biopharma, Inc.
RESEARCH TRIANGLE PARK, N.C., April 1 /PRNewswire-FirstCall/ -- Hemispherx Biopharma, Inc.
PHILADELPHIA, Jan. 5 /PRNewswire/ -- The law firm of Berger & Montague, P.C. has filed a class action in the U.S. District Court for the Eastern District of Pennsylvania that expands the proposed class period to include all purchasers of Hemispherx Biopharma, Inc.
MEDIA, Pa., Dec.
CLINTON, N.J., May 27 /PRNewswire/ -- The Sage Group, a privately held international health care consulting group, announced today that HemispherX Biopharma has expanded the mandate for The Sage Group to include, in addition to the strategic partnering efforts related to Ampligen (an experimental immunotherapeutic) for Chronic Fatigue Syndrome*, additional partnering efforts related to Ampligen's use to increase the effectiveness of preventative pandemic flu vaccines and the additional role...
- Inward knowledge; understanding; conscience.